Geron ( GERN) develops therapeutic products for cancer that inhibit telomerase. This stock is trading up 3.1% to $1.16 in recent trading.
Today's Range: $1.13-$1.16
52-Week Range: $0.91-$2.99
Three-Month Average Volume: 767,800
52-Week Range: $3.09-$17.35
Volume: 1.43 million
Three-Month Average Volume: 267,956 >>5 Hated Earnings Stocks That Deserve Your Love Shares of ROSG are ripping higher today after the company announced plans to expand its U.S. commercial footprint from five sales territories currently to 12 territories beginning in July. The company also reported the successful launch of its new corporate and product branding at the recent American Society of Clinical Oncology Annual Meeting. From a technical perspective, ROSG is soaring higher her right off its 50-day moving average at $3.74 with heavy upside volume. This move is quickly pushing shares of ROSG within range of triggering a near-term breakout trade. That trade will hit if ROSG manages to take out some near-term overhead resistance at $4.15 with high volume. At last check, ROSG has started to flirt with that breakout since the stock has hit an intraday high of $4.22 and volume is well above its three-month average action of 267,956 shares.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts